Page last updated: 2024-09-03

efaproxiral and Animal Mammary Carcinoma

efaproxiral has been researched along with Animal Mammary Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Donnelly, ET; Liu, Y; Rockwell, S1

Other Studies

1 other study(ies) available for efaproxiral and Animal Mammary Carcinoma

ArticleYear
Efaproxiral (RSR13) plus oxygen breathing increases the therapeutic ratio of carboplatin in EMT6 mouse mammary tumors.
    Experimental biology and medicine (Maywood, N.J.), 2006, Volume: 231, Issue:3

    Topics: Alkylating Agents; Aniline Compounds; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Male; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Oxygen; Propionates; Respiration; Time Factors

2006